<?xml version="1.0" encoding="UTF-8"?>
<ref id="R3">
 <label>3</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Zoulim</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Liang</surname>
   <given-names>TJ</given-names>
  </string-name>, 
  <string-name>
   <surname>Gerbes</surname>
   <given-names>AL</given-names>
  </string-name>, 
  <string-name>
   <surname>Aghemo</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Deuffic-Burban</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Dusheiko</surname>
   <given-names>G</given-names>
  </string-name>, 
  <etal>et al.</etal>
  <article-title>Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.</article-title>
  <source>Gut</source>. 
  <year>2015</year>
  <month>11</month>;
  <volume>64</volume>(
  <issue>11</issue>):
  <fpage>1824</fpage>â€“
  <lpage>33</lpage>. 
  <pub-id pub-id-type="doi">10.1136/gutjnl-2015-310421</pub-id>
  <?supplied-pmid 26449729?>
  <pub-id pub-id-type="pmid">26449729</pub-id>
 </mixed-citation>
</ref>
